AIMS: To investigate whether hypoxia-inducible factor (HIF) 1alpha and cyclosporin A (CsA) can regulate MICA/B expression and affect NK cytotoxicity during ischemia/reperfusion (I/R) injury. MAIN METHODS: We generated an HIF-1alphaDeltaODD-expressing adenovirus which can functionally and steadily express HIF-1alpha during normoxia and transfected human cardiomyocytes (HCMs) to investigate whether HIF-1alpha, as a single factor, can upregulate MICA/B expression. Alternatively, HCMs were treated with HIF-1alpha RNAi or CsA, and then cultured under hypoxia/reoxygenation (H/R) condition to simulate I/R injury in vitro. Cells were collected at different time points and used for studies of gene expression and NK cytotoxicity. KEY FINDINGS: Expression of MICA/B in HCMs is upregulated through HIF-1alpha overexpression in normoxia, and inhibited by HIF-1alpha RNAi treatment during hypoxia-reoxygenation (H/R). NK cytotoxicity towards HCMs shows a positive correlation with HIF-1alpha expression. Moreover, CsA can inhibit HIF-1alpha and MICB expression but upregulates MICA expression during H/R. SIGNIFICANCE: These findings suggest that proper control of HIF-1alpha expression via CsA dose may be a potential therapeutic approach for avoiding MIC expression, and improving the function and long-term survival of heart allografts. Copyright 2010 Elsevier Inc. All rights reserved.
AIMS: To investigate whether hypoxia-inducible factor (HIF) 1alpha and cyclosporin A (CsA) can regulate MICA/B expression and affect NK cytotoxicity during ischemia/reperfusion (I/R) injury. MAIN METHODS: We generated an HIF-1alphaDeltaODD-expressing adenovirus which can functionally and steadily express HIF-1alpha during normoxia and transfected human cardiomyocytes (HCMs) to investigate whether HIF-1alpha, as a single factor, can upregulate MICA/B expression. Alternatively, HCMs were treated with HIF-1alpha RNAi or CsA, and then cultured under hypoxia/reoxygenation (H/R) condition to simulate I/R injury in vitro. Cells were collected at different time points and used for studies of gene expression and NK cytotoxicity. KEY FINDINGS: Expression of MICA/B in HCMs is upregulated through HIF-1alpha overexpression in normoxia, and inhibited by HIF-1alpha RNAi treatment during hypoxia-reoxygenation (H/R). NK cytotoxicity towards HCMs shows a positive correlation with HIF-1alpha expression. Moreover, CsA can inhibit HIF-1alpha and MICB expression but upregulates MICA expression during H/R. SIGNIFICANCE: These findings suggest that proper control of HIF-1alpha expression via CsA dose may be a potential therapeutic approach for avoiding MIC expression, and improving the function and long-term survival of heart allografts. Copyright 2010 Elsevier Inc. All rights reserved.
Authors: L Wei; M Wang; X Qu; A Mah; X Xiong; A G C Harris; L K Phillips; O M Martinez; S M Krams Journal: Am J Transplant Date: 2012-02-02 Impact factor: 8.086
Authors: Maria Teresa Palano; Martina Cucchiara; Matteo Gallazzi; Federica Riccio; Lorenzo Mortara; Gian Franco Gensini; Gaia Spinetti; Giuseppe Ambrosio; Antonino Bruno Journal: Front Immunol Date: 2022-01-13 Impact factor: 7.561
Authors: Francisco Victorino; Dorothy K Sojka; Kelley S Brodsky; Eoin N McNamee; Joanne C Masterson; Dirk Homann; Wayne M Yokoyama; Holger K Eltzschig; Eric T Clambey Journal: J Immunol Date: 2015-10-09 Impact factor: 5.422
Authors: Beatriz Suárez-Álvarez; Alba Fernández-Sánchez; Antonio López-Vázquez; Eliecer Coto; Francisco Ortega; Carlos López-Larrea Journal: Kidney Int Suppl (2011) Date: 2011-08